These Terms and Conditions govern the way readers use the sermorelin-injection.com editorial site, published by the Executive Medical, LLC editorial team. By browsing this domain you accept the terms below. If you do not agree with any part of them, please stop using the site.
Nature of the content. The pages on this site discuss sermorelin and adjacent peptide therapies as a journalistic and reference subject. We summarize clinical literature, regulatory framings such as 503A and 503B compounding, and the way US telehealth services are typically organized. The material is written for an adult audience and is general in nature. It is not a substitute for an in-person evaluation by a licensed clinician and it does not create a doctor-patient relationship.
Intellectual property. All editorial text, article structure, headings, infographics and original photography on this site are the property of the Executive Medical, LLC editorial team unless an explicit credit is given to a third party. Short quotations may be reproduced elsewhere with a clear link back to the source page. Wholesale republication, scraping for AI training datasets, or redistribution of full articles without written permission is not authorized. Brand names and trademarks of compounding pharmacies, manufacturers or telehealth platforms that appear in the text remain the property of their respective owners and are used only in a descriptive editorial context.
No warranty. The information on health topics is provided “as is”. We make a good-faith effort to verify clinical claims against the underlying literature and to flag uncertainty where it exists, but pharmacology evolves and individual circumstances vary. We cannot warrant that a given statement is complete, current or applicable to a specific reader. Readers should treat anything they read here as a starting point for a conversation with a licensed clinician in their own state, not as a finished medical opinion.
Limit of liability. To the maximum extent permitted by applicable law, the Executive Medical, LLC editorial team, our contributors and our infrastructure vendors are not liable for any direct, indirect, incidental or consequential damages arising from the use of, or inability to use, this site, including any decision made on the basis of an article. Health-related decisions are the responsibility of the reader and their clinician.
Acceptable use. Readers agree not to misuse the contact form for spam, to attempt to reverse-engineer or attack the site, to mass-scrape pages, or to upload malicious content. We may block IP ranges, throttle automated traffic or remove abusive submissions at our discretion.
External links. The articles may link out to government agencies, journal databases, professional societies or other editorial publications. We do not control the content on those external destinations and we are not responsible for changes that occur there after we publish.
Governing law and disputes. These Terms are construed under the laws of the country in which the Executive Medical, LLC editorial team is established. Disputes will first be addressed through good-faith correspondence. If they cannot be resolved that way, they will be brought before the competent courts of the jurisdiction in which the editorial office is registered.
Modifications. We may update these Terms when our editorial workflow, our vendor stack, or applicable regulations change. The current version is always the one displayed at . Material changes are flagged in the footer of the page with a fresh effective date. Continued use of the site after the new version is posted means you accept it.
Questions about these Terms can be sent via the contact form, by phone at or by post to Ready Health Ventures Inc., 1007 N Orange St. 4th Floor Ste 1382, Wilmington, Delaware, 19801.
What sermorelin injection actually is
For adults across the United States, USA, sermorelin is a 29-amino-acid peptide that mimics the first portion of natural growth hormone releasing hormone (GHRH). When injected subcutaneously, sermorelin signals the pituitary gland to release the body's own growth hormone in a pulsatile, physiologic pattern. This is the key difference from synthetic human growth hormone (HGH): sermorelin asks the body to produce its own GH, rather than supplying GH from outside.
Because of that mechanism, sermorelin therapy is typically prescribed for adults whose GH output has declined with age. It is dispensed in the United States as a compounded subcutaneous injection from licensed 503A and 503B pharmacies, and it requires a written prescription from a clinician after consultation and lab work.
How treatment is initiated in the United States, USA
- Intake and lab order. You complete a health history online. A licensed clinician orders a baseline blood panel that includes IGF-1, fasting glucose and a complete metabolic profile.
- Clinical review. A US-licensed clinician reviews your labs against your goals and confirms that sermorelin is medically appropriate. If it is not, the consultation is refunded in full.
- Compounded prescription. The prescription is written to a partner compounding pharmacy. Sermorelin is shipped to your address across the United States, USA with syringes, alcohol pads and dosing instructions.
- Self-administration. Most protocols use a single subcutaneous injection at night, on an empty stomach, to align with natural GH pulse. A 1:1 health coach is included to walk you through the first weeks.
Who tends to consider sermorelin
Residents of the United States typically enter consultation between 30 and 65 years old, when the downstream effects of declining growth hormone output begin to surface. The most common reasons people pursue sermorelin are listed below.
- Reduced recovery from training, harder to gain or hold lean mass
- Sleep that feels lighter and less restorative than it used to
- Visible changes in body composition, especially abdominal fat
- Lower energy in the late afternoon and softer libido
- Slower healing from minor injuries, joint and connective tissue discomfort
- Mental fog or reduced focus across the day
None of these reasons in isolation is a diagnosis. They are screening signals that justify a real clinical conversation, lab work and a personalized protocol. Sermorelin is not prescribed for performance enhancement and is not marketed for cosmetic anti-aging.
Frequently asked questions
How long until results appear?
Most reported changes follow a predictable curve. Sleep depth and morning energy typically shift in the first 30 days. Skin, hair and metabolic markers tend to move in the second month. Body composition, libido and joint comfort are usually evaluated at the three month mark, when a follow-up lab is recommended.
Is sermorelin the same as HGH?
No. HGH is the growth hormone molecule itself. Sermorelin is a releasing peptide that prompts the body to produce its own GH in a natural pulsatile rhythm. This avoids the supraphysiological peaks that direct HGH injection can produce.
Is sermorelin FDA approved?
The original brand version of sermorelin was discontinued. The form prescribed today is a compounded medication dispensed by licensed compounding pharmacies under federal sections 503A and 503B. Compounded preparations are not separately FDA approved, and that disclosure is provided at consultation.
Is sermorelin legal in my state?
Sermorelin is legal across the United States when prescribed by a US-licensed clinician. Each state medical board sets its own scope-of-practice rules, but compounded sermorelin dispensed under federal 503A and 503B is permitted across all 50 states.
Do I need insurance?
No. Most patients pay out of pocket. HSA and FSA cards are accepted by most telehealth providers. The consultation, labs and three month supply are usually billed as a single program.
Where do I inject?
Subcutaneous injection into the abdomen at least one inch from the navel, or into the outer thigh. The injection is small (insulin syringe gauge), administered nightly on an empty stomach. The protocol is typically five days on, two days off.
What if treatment is not appropriate for me?
If the clinician reviewing your intake decides sermorelin is not medically necessary, the consultation fee is refunded in full and no prescription is issued. This is built into the licensed telehealth model and is verifiable in the provider's terms.
Ready to speak with a clinician in the United States, USA
The consultation is online, the lab can be drawn at home, and treatment ships to your door if you qualify.
Start your consultation